Vol. 1 No. 2 (2026): TRANSITIONING TO ROBOTIC COMPLETE MESOCOLIC EXCISION WITH CENTRAL VASCULAR LIGATION
Vol. 1, Issue No. 2 | July 2026
Robotic-assisted colorectal surgery continues to reshape the landscape of minimally invasive cancer treatment by offering enhanced precision, improved visualization, and greater surgical dexterity. As the adoption of robotic platforms increases worldwide, evaluating their clinical effectiveness and oncological safety compared with established laparoscopic techniques has become increasingly important.
This research article in the Journal of the European Society of Surgery (JESS) presents a propensity score-matched retrospective cohort study comparing robotic complete mesocolic excision (CME) with central vascular ligation (CVL) against standard laparoscopic right hemicolectomy. The study evaluates perioperative outcomes, postoperative complications, oncological quality, and patient safety to assess the clinical impact of robotic surgery in right-sided colon cancer.
The findings demonstrate that robotic CME with CVL provides comparable short-term clinical and oncological outcomes while offering the technical advantages of enhanced visualization, improved instrument control, and precise dissection during complex colorectal procedures. This study contributes valuable evidence supporting the safe implementation of robotic-assisted colorectal surgery and serves as an important resource for colorectal surgeons, surgical oncologists, researchers, and healthcare professionals involved in minimally invasive gastrointestinal surgery.
